LACOG investigator Dr. Theodora Karnakis, member of the Geriatric Group Steering Committee, presented three contributions at SIOG 2026: an oral presentation on geriatric assessment and two posters on geriatric oncology in Brazil.

#LACOG #SIOG2026 #InvestigatorsAroundTheWorld

At SIOG 2026, Dr. Andrea Shimada presented findings from the FRAGILE study (LACOG 1425), which evaluated the adoption of comprehensive geriatric assessment and barriers to its implementation in cancer care for older adults in Latin America.

#LACOG #SIOG2026 #GeriatricOncology

At SIOG 2026, Dr. Andrea Shimada presented findings from the FRAGILE study (LACOG 1425), which evaluated the adoption of comprehensive geriatric assessment and barriers to its implementation in cancer care for older adults in Latin America.

#LACOG #SIOG2026 #GeriatricOncology

LACOG announces the new members of the Brazil Board of its Neurological Group.

They will help guide the group's activities and strategic priorities from 2026 to 2028, advancing clinical and epidemiological research.

#LACOG #CancerResearch

LACOG announces the new members of the LATAM Board of its Neurological Group.

They will help guide the group's activities and strategic priorities from 2026 to 2028, advancing clinical and epidemiological research.

#LACOG #CancerResearch

Em alusão ao Outubro Rosa, o LACOG Office promoveu um bate-papo sobre prevenção do câncer de mama com a Dra. Alessandra Borba, mastologista, e o Dr. Gustavo Werutsky, oncologista e investigador em câncer de mama e diretor executivo do LACOG.

#LACOG #OutubroRosa

LACOG will be presenting at #SIOG2026 with a poster of findings from the FRAGILE study (LACOG 1425) on the adoption of comprehensive geriatric assessment in Latin America. PI: Larissa Moura Matos; Co-PI: Clarissa Cavalin Silva; presenter: Andrea Shimada.

#LACOG

ESMO Congress 2026 in Madrid brought meaningful encounters, knowledge exchange, and scientific discussions for LACOG and Latin American researchers. These photos capture moments from the congress and exchanges with colleagues from different countries.

#LACOG #ESMO2026

ESMO Congress 2026 in Madrid brought meaningful encounters, knowledge exchange, and scientific discussions for LACOG and Latin American researchers. These photos capture moments from the congress and exchanges with colleagues from different countries.

#LACOG #ESMO2026

At ESMO Congress 2026, Dr. Carlos Barrios, one of LACOG’s founders, highlights the growth of oncology research in Latin America, the group’s progress, and how a new generation of researchers is strengthening the region’s contribution to science and cancer care.

#LACOG #ESMO2026

Breast cancer research in Latin America is strengthened by collaboration across countries and institutions. At ESMO Congress 2026 in Madrid, Paula Anel Cabrera Galeana, Chair of the LACOG Breast Cancer Group LATAM, is part of the region’s research community.

#LACOG #ESMO2026

The ESMO Congress 2026 brought together important discussions on advances in gynecological cancer. Dr. Angélica Nogueira, Vice-Chair of the LACOG Gynecological Group, shares highlights from the congress in Madrid.

Watch the full video.

#LACOG #ESMO2026

Latin America’s role in international oncology research is growing. At ESMO Congress 2026, Dr. Gustavo Gössling, Clinical Research Physician at LACOG, highlights the region’s participation in key studies and its growing importance in global cancer research.

#LACOG #ESMO2026

Dr. Alexandre Jácome, Co-Chair of the LACOG Gastrointestinal Group, shares his insights on key gastrointestinal cancer highlights from the ESMO Congress 2026 in Madrid and discusses the potential implications of the studies presented for clinical practice.

Watch the full video.

At ESMO 2026, Dr. Andréia Cristina de Melo presented findings from the MADONNA study (LACOG 0521-EVA), characterizing endometrial cancer in Brazil. The study included 280 patients from 12 sites, assessing demographic and clinical profiles, treatment patterns, and outcomes.
#LACOG

At ESMO 2026, Dr. Fernando Maluf, a LACOG investigator, chaired a session on penile cancer and presented on lymph node-positive and metastatic disease. The session also highlighted LACOG-led studies exploring new treatments for advanced penile cancer.

#LACOG #LACOGGU #ESMO2026

At ESMO 2026, Dr. Fernando Maluf, a LACOG investigator, chaired a session on penile cancer and presented on lymph node-positive and metastatic disease. The session also highlighted LACOG-led studies exploring new treatments for advanced penile cancer.

#LACOG #LACOGGU #ESMO2026

At ESMO 2026, Dr. Fernanda C. Casarotto presented poster 1337TiP from Symbiotic-GYN-18 (LACOG 0426-EVA), a phase 3 study evaluating a PD-1/VEGF bispecific antibody plus chemotherapy for advanced or recurrent pMMR endometrial cancer.

#LACOG #ESMO2026

At ESMO 2026, LACOG is presenting research findings and discussing clinical research opportunities for Latin America.

Dr. Taiane Rebelatto, LACOG’s Medical Director, highlights the importance of sharing research advances and fostering collaboration across the region.

#ESMO2026

At ESMO 2026, Dr. Thiago Bueno de Oliveira presented SMART-KEY (LACOG 0720), a study of a cisplatin-free, pembrolizumab-based strategy to preserve the larynx in locally advanced laryngeal cancer.

Abstract 1537RO
#LACOG #ESMO2026